4//SEC Filing
Ahrens Brenton Karl 4
Accession 0001209191-22-021543
CIK 0001659323other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 8:00 PM ET
Size
5.5 KB
Accession
0001209191-22-021543
Insider Transaction Report
Form 4
Ahrens Brenton Karl
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-25+47,436→ 47,436 totalExercise: $0.45Exp: 2032-03-26→ Ordinary Shares (47,436 underlying)
Footnotes (1)
- [F1]Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated Equity Incentive Plan, as amended, the shares subject to this option shall vest on January 1, 2023.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001322927
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 8:00 PM ET
- Size
- 5.5 KB